Shares of Ardent Health, Inc. (NYSE:ARDT – Get Free Report) have earned an average rating of “Hold” from the fourteen research firms that are presently covering the firm, MarketBeat Ratings reports. Two research analysts have rated the stock with a sell rating, five have given a hold rating and seven have assigned a buy rating to the company. The average 1 year price target among analysts that have issued a report on the stock in the last year is $14.1250.
ARDT has been the topic of several recent research reports. Royal Bank Of Canada dropped their target price on Ardent Health from $13.00 to $12.00 and set an “outperform” rating on the stock in a research report on Thursday. UBS Group upped their price objective on Ardent Health from $13.00 to $13.50 and gave the stock a “buy” rating in a research note on Thursday, May 7th. Wall Street Zen downgraded Ardent Health from a “buy” rating to a “hold” rating in a research report on Sunday. Zacks Research upgraded Ardent Health from a “strong sell” rating to a “hold” rating in a research note on Wednesday, March 25th. Finally, Weiss Ratings reiterated a “sell (d+)” rating on shares of Ardent Health in a report on Friday, June 12th.
Read Our Latest Stock Analysis on ARDT
Insider Buying and Selling at Ardent Health
Institutional Investors Weigh In On Ardent Health
Hedge funds and other institutional investors have recently bought and sold shares of the company. LSV Asset Management purchased a new position in Ardent Health in the fourth quarter worth $963,000. Prescott Group Capital Management L.L.C. purchased a new stake in shares of Ardent Health during the 4th quarter valued at $1,077,000. Denali Advisors LLC lifted its holdings in shares of Ardent Health by 35.0% during the 4th quarter. Denali Advisors LLC now owns 249,450 shares of the company’s stock valued at $2,203,000 after purchasing an additional 64,650 shares during the last quarter. Strs Ohio boosted its position in shares of Ardent Health by 47.2% in the 4th quarter. Strs Ohio now owns 62,400 shares of the company’s stock worth $551,000 after purchasing an additional 20,000 shares in the last quarter. Finally, Zurcher Kantonalbank Zurich Cantonalbank boosted its position in shares of Ardent Health by 126.1% in the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 10,400 shares of the company’s stock worth $92,000 after purchasing an additional 5,800 shares in the last quarter.
Ardent Health Price Performance
NYSE ARDT opened at $10.10 on Monday. The company has a debt-to-equity ratio of 0.62, a quick ratio of 2.00 and a current ratio of 2.12. The firm’s 50 day moving average price is $9.60 and its 200-day moving average price is $9.26. Ardent Health has a 52-week low of $7.71 and a 52-week high of $15.48. The company has a market cap of $1.45 billion, a PE ratio of 10.63, a P/E/G ratio of 2.29 and a beta of 0.76.
Ardent Health (NYSE:ARDT – Get Free Report) last issued its quarterly earnings data on Tuesday, May 5th. The company reported $0.28 EPS for the quarter, topping analysts’ consensus estimates of $0.18 by $0.10. The company had revenue of $1.60 billion during the quarter, compared to the consensus estimate of $1.58 billion. Ardent Health had a net margin of 2.09% and a return on equity of 13.85%. Ardent Health has set its FY 2026 guidance at 0.900-1.270 EPS. Sell-side analysts forecast that Ardent Health will post 1.1 EPS for the current fiscal year.
Ardent Health Company Profile
Ardent Health, listed on the New York Stock Exchange under the ticker ARDT, is a healthcare delivery company focused on acquiring, developing and managing acute care hospitals and complementary outpatient facilities across the United States. The company’s integrated platform encompasses both inpatient and outpatient services, designed to provide end-to-end care solutions and address the full continuum of patient needs.
Through its network, Ardent Health operates general hospitals, emergency departments, ambulatory surgery centers, urgent care clinics, rehabilitation and post-acute care facilities.
Featured Articles
- Five stocks we like better than Ardent Health
- 3 Rare-Earth ETFs That Help Investors Balance Exposure and Risk
- Microsoft Bets on In-House AI to Cut OpenAI and Anthropic Costs
- Delta Air Lines Lives Up to Its Claims: Shares Can Keep Climbing
- This Dividend ETF Choice Could Shape Your Income Strategy Through 2026
Receive News & Ratings for Ardent Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ardent Health and related companies with MarketBeat.com's FREE daily email newsletter.
